Design, operation, and interpretation of clinical trials

Journal of Dental Research

Volumn 89, Issue 8, 2010, Pages 759-772

  Pihlstrom, B L ^a   Barnett, M L ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

clinical research; clinical trials; oral health research

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL TRIAL; DENTAL RESEARCH; HUMAN; METHODOLOGY; MULTICENTER STUDY; REVIEW; SAMPLE SIZE; STANDARD; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DENTAL RESEARCH; HUMANS; MULTICENTER STUDIES AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 77955494003     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510374737     Document Type: Article

References (102)

1. American Dental Association (2008). ADA Policy Statement on Evidence-Based Dentistry. http://www.ada.org/1754.aspx (URL accessed 05/05/2010).
2. Balas EA (2001). Information systems can prevent errors and improve quality. J Am Med Inform Assoc 8: 398-399.
3. Barnett ML, Pihlstrom BL (2004). Methods for enhancing the efficiency of dental/oral health clinical trials: current status, future possibilities. J Dent Res 83: 744-750.
4. Bellinger DC, Daniel D., Trachtenberg F., Tavares M., McKinlay S. (2007 a). Dental amalgam restorations and childrens neuropsychological function: the New England Childrens Amalgam Trial. Environ Health Perspect 115: 440-446.
5. Bellinger DC, Trachtenberg F., Daniel D., Zhang A., Tavares MA, McKinlay S. (2007 b). A dose-effect analysis of childrens exposure to dental amalgam and neuropsychological function: the New England Childrens Amalgam Trial. J Am Dent Assoc 138: 1210-1216.
6. Blackwelder WC (2004). Current issues in clinical equivalence trials. J Dent Res 83 (Spec Iss C). C113 - C115.
7. Buckley DI, Fu R., Freeman M., Rogers K., Helfand M. (2009). C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 151: 483-495.
8. California Dental Association Foundation (2010 a). Oral Health During Pregnancy & Early Childhood: Evidence-Based Guidelines for Health Professionals. Sacramento, CA, USA: CDA Foundation, http://www.cdafoundation. org/library/docs/poh-guidelines.pdf (URL accessed 05/05/2010).
9. California Dental Association Foundation (2010 b). Oral Health During Pregnancy & Early Childhood: policy brief. Sacramento, CA, USA: CDA Foundation, http://www.cdafoundation.org/library/docs/poh-policy-brief.pdf (URL accessed 05/05/2010).
10. Carter RE (2004). Application of stochastic processes to participant recruitment in clinical trials. Control Clin Trials 25: 429-436.
11. ClinicalTrials.gov (2010 a). Understanding Clinical Trials. http://clinicaltrials.gov/ct2/info/understand (URL accessed 05/05/2010).
12. ClinicalTrials.gov (2010 b). Protocol Registration System. http://prsinfo.clinicaltrials.gov/ (URL accessed 05/05/2010).
13. ClinicalTrials.gov (2010c). http://clinicaltrials.gov/ct2/info/about (URL accessed 05/05/2010).
14. Current Controlled Clinical Trials (2010). http://www.controlled-trials. com/ (URL accessed 05/05/2010).
15. DeAngelis CD, Drazen JM, Frizelle FA, Haug C., Hoey J., Horton R., et al. (2004). Clinical trial registration: a statement from the International Committee of Medical Journal Editors. J Am Med Assoc 292: 1363-1364.
16. DeRouen TA, Martin MD, Leroux BG, Townes BD, Woods JS, Leitão J., et al. (2006). Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. J Am Med Assoc 295: 1784-1792.
17. Dickersin K., Rennie D. (2003). Registering clinical trials. J Am Med Assoc 290: 516-523.
18. Downing GJ (2000). Biomarkers and surrogate endpoints: clinical research and applications. Proceedings of an NIH-FDA Conference, April 15-16, 1999, Bethesda, MD, USA. New York: Elsevier Publishers, pp. 1-9.
19. Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Steg PG, Cannon CP, et al. (2009). Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the United States: insights from the REACH Registry. Crit Pathw Cardiol 8: 91-97.
20. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D., Barker AH, et al. (1991). Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324: 781-788.
21. Evans CH Jr, Ildstad ST (2001). Executive summary. In: Small clinical trials-issues and challenges. Washington, DC: Institute of Medicine, National Academy Press, pp. 1-11.
22. Friedman LM, Furberg CD, DeMets DL (1998 a). Fundamentals of clinical trials. 3 rd ed. New York: Springer Publishers, p. 2.
23. Friedman LM, Furberg CD, DeMets DL (1998 b). Ibid., pp. 16-29.
24. Friedman LM, Furberg CD, DeMets DL (1998 c). Ibid., pp. 61-81.
25. Friedman LM, Furberg CD, DeMets DL (1998 d). Ibid., pp. 82-93.
26. Friedman LM, Furberg CD, DeMets DL (1998 e). Ibid., pp. 304-305.
27. Friedman LM, Furberg CD, DeMets DL (1998 f). Ibid., pp. 345-356.
28. GlaxoSmithKline (2010). Clinical Trial Registry. http://www.gsk- clinicalstudyregister.com/ (URL accessed 05/05/2010).
29. Greenstein G. (2003). Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. J Am Dent Assoc 134: 583-591.
30. Heitjan DF (1999). Causal inference in a clinical trial: a comparative example. Control Clin Trials 20: 309-318.
31. Helfand M., Buckley DI, Freeman M., Fu R., Rogers K., Fleming C., et al. (2009). Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U. S. Preventive Services Task Force. Ann Intern Med 151: 496-507.
32. Helsinki Declaration of the World Medical Association (1964). http://ohsr.od.nih.gov/guidelines/Helsinki.html (URL accessed 05/05/2010).
33. Hodges JS (2008). Intention-to-treat has implications for study planning and execution, not just subject retention and follow-up. J Clin Periodontol 35: 683-684.
34. Hopewell S., Altman DG, Moher D., Schulz KF (2008). Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal Instructions to Authors. Trials 9: 20.
35. Hujoel PP (1998). Design and analysis issues in split-mouth clinical trials. Community Dent Oral Epidemiol 26: 85-86.
36. Hujoel PP, DeRouen TA (1992). Validity issues in split-mouth trials. J Clin Periodontol 19 (9 Pt 1). 625-627.
37. Hujoel PP, Loesche WJ (1990). Efficiency of split-mouth designs. J Clin Periodontol 17: 722-728.
38. Hujoel PP, Drangsholt M., Spiekerman C., DeRouen TA (2000). Periodontal disease and coronary heart disease risk. J Am Med Assoc 284: 1406-1410.
39. Hujoel PP, Drangsholt M., Spiekerman C., DeRouen TA (2002). Pre-existing cardiovascular disease and periodontitis: a follow-up study. J Dent Res 81: 186-191.
40. Hyman J. (2006). The importance of assessing confounding and effect modification in research involving periodontal disease and systemic diseases. J Clin Periodontol 33: 102-103.
41. Jadad AR, Rennie D. (1998). The randomized controlled trial gets a middle-aged checkup. J Am Med Assoc 279: 319-320.
42. Lasagna L. (1979). Problems in publication of clinical trial methodology. Clin Pharmacol Ther 25 (5 Pt 2). 751-753.
43. Laster LL, Johnson MF (2003). Non-inferiority trials: the at least as good as criterion. Stat Med 22: 187-200.
44. Lauterbach M., Martins IP, Castro-Caldas A., Bernardo M., Luis H., Amaral H., et al. (2008). Neurological outcomes in children with and without amalgam-related mercury exposure: seven years of longitudinal observations in a randomized trial. J Am Dent Assoc 139: 138-145.
45. Laviola M., McGavin SK, Freer GA, Plancich G., Woodbury SC, Marinkovich S., et al. (2008). Randomized study of phentolamine mesylate for reversal of local anesthesia. J Dent Res 87: 635-639.
46. Lawrence HP, Binguis D., Douglas J., McKeown L., Switzer B., Figueiredo R., et al. (2008). A 2-year community-randomized controlled trial of fluoride varnish to prevent early childhood caries in Aboriginal children. Community Dent Oral Epidemiol 36: 503-516.
47. Lenth RV (2009). Java Applets for Power and Sample Size [computer software]. http://www.stat.uiowa.edu/∼rlenth/Power/ (URL accessed 05/05/2010).
48. Lerman A., Zeiher AM (2005). Endothelial function: cardiac events. Circulation 111: 363-368.
49. Lesaffre E. (2008). Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis 66: 150-154.
50. Lesaffre E., Garcia Zattera MJ, Redmond C., Huber H., Needleman I. (2007). Reported methodological quality of split-mouth studies. J Clin Periodontol 34: 756-761.
51. Lesaffre E., Pihlstrom B., Needleman I., Worthington H. (2009). The design and analysis of split-mouth studies: what statisticians and clinicians should know. Stat Med 28: 3470-3482.
52. Lopez NJ, Smith PC, Gutierrez J. (2002). Periodontal therapy may reduce the risk of preterm low birth weight in women with periodontal disease: a randomized controlled trial. J Periodontol 73: 911-924.
53. Lopez NJ, Da Silva I., Ipinza J., Gutierrez J. (2005). Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy-associated gingivitis. J Periodontol 76 (11 Suppl). S2144 - S2153.
54. Lundh A., Getzsche P. (2008). Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. http://www.biomedcentral.com/ 1471-2288/8/22/ (URL accessed 05/05/2010).
55. Machtei EE, Younis MN (2008). The use of 2 antibiotic regimens in aggressive periodontitis: comparison of changes in clinical parameters and gingival crevicular fluid biomarkers. Quintessence Int 39: 811-819.
56. Macones GA, Parry S., Nelson DB, Strauss JF, Ludmir J., Cohen AW, et al. (2010). Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol 202: 147.e1 - e8.
57. Manolio T. (2002). Design and conduct of observational studies and clinical trials. In: Principles and practice of clinical research. Gallin JI, editor. San Diego, CA: Academic Press Publishers, pp. 187-206.
58. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, et al. (2006). What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 7: 9.
59. Meinert CL (1986 a). Coordinating and other resource centers in multicenter trials. In: Clinical trials-design, conduct, and analysis. New York: Oxford University Press, pp. 30-39.
60. Meinert CL (1986 b). Appendix G. Sample of operations, handbook, and monitoring report. In: Clinical trials-design, conduct, and analysis. New York: Oxford University Press, pp. 417-424.
61. Meinert CL (1998). Masked monitoring in clinical trials-blind stupidity ? N Engl J Med 338: 1381-1382.
62. Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, Ferguson JE, et al. (2006). Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 355: 1885-1894.
63. Michalowicz BS, DiAngelis AJ, Novak MJ, Buchanan W., Papapanou PN, Mitchell DA, et al. (2008). Examining the safety of dental treatment in pregnant women. J Am Dent Assoc 139: 685-695.
64. Michalowicz BS, Novak MJ, Hodges JS, DiAngelis A., Buchanan W., Papapanou PN, et al. (2009). Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes. J Periodontol 80: 1731-1741.
65. Milgrom PM, Hujoel PP, Weinstein P., Holborow DW (1997). Subject recruitment, retention, and compliance in clinical trials in periodontics. Ann Periodontol 2: 64-74.
66. Moher D., Schulz K., Altman D. CONSORT Group (2003). The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Clin Oral Investig 7: 2-7.
67. Molenberghs G., Kenward MG (2007). Missing data in clinical studies. New York: John Wiley & Sons Ltd.
68. National Institute of Diabetes and Digestive and Kidney Diseases (2009). DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study. http://diabetes.niddk.nih.gov/dm/pubs/control/ (URL accessed 05/05/2010).
69. Needleman I., Worthington H., Moher D., Schulz K., Altman DG (2008). Improving the completeness and transparency of reports of randomized trials in oral health: the CONSORT statement. Am J Dent 21: 7-12.
70. Newnham JP, Newnham IA, Ball CM, Wright M., Pennell CE, Swain J., et al. (2009). Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet Gynecol 114: 1239-1248.
71. Nuremberg Code (1996). Nuremberg Military Tribunal. J Am Med Assoc 276: 1691.
72. Obstetrics and Periodontal Therapy (OPT) Study Manual of Operations (2003). http://www.biostat.umn.edu/∼hodges/MOP-IndexVersion07-0803.doc (URL accessed 05/11/2010).
73. Offenbacher S., Lin D., Strauss R., McKaig R., Irving J., Barros SP, et al. (2006). Effects of periodontal therapy during pregnancy on periodontal status, biologic parameters, and pregnancy outcomes: a pilot study. J Periodontol 77: 2011-2024.
74. Offenbacher S., Beck JD, Moss K., Mendoza L., Paquette DW, Barrow DA (2009 a). Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 80: 190-201.
75. Offenbacher S., Beck JD, Jared HL, Mauriello SM, Mendoza LC, Couper DJ, et al. (2009b). Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol 114: 551-559.
76. Pocock SJ (2007 a). Clinical trials: a practical approach. New York, NY: John Wiley & Sons Ltd., 1983 ; reprinted 2007, p. 3.
77. Pocock SJ (2007 b). Ibid., pp. 52-54.
78. Pocock SJ (2007 c). Ibid., p. 125.
79. Pocock SJ (2007 d). Ibid., pp. 207-210.
80. Prochaska JO, Evers KE, Prochaska JM, Van Marter D., Johnson JL (2007). Efficacy and effectiveness trials: examples from smoking cessation and bullying prevention. J Health Psychol 12: 170-178.
81. Radnai M., Pal A., Novak T., Urban E., Eller J., Gorzo I. (2009). Benefits of periodontal therapy when preterm birth threatens. J Dent Res 88: 280-284.
82. Ramfjord SP, Nissle RR, Shick RA, Cooper H. Jr (1968). Subgingival curettage versus surgical elimination of periodontal pockets. J Periodontol 39: 167-175.
83. Renvert S., Lindahl C., Roos-Jansaker AM, Lessem J. (2009). Short-term effects of an anti-inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis J Periodontol 80: 892-900.
84. Ridker PM, Paynter NP, Rifai N., Gaziano JM, Cook NR (2008 a). C-reactive protein and parental history improve global cardiovascular risk prediction. Circulation 118: 2243-2251.
85. Ridker PM, Danielson E., Fonseca FA, Genest J., Gotto AM Jr, Kastelein JJ, et al. (2008 b). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207.
86. Ross S. (2007). Composite outcomes in randomized clinical trials: arguments for and against. Am J Obstet Gynecol 196: 119.e1 - e6.
87. Sadatmansouri S., Sedighpoor N., Aghaloo M. (2006). Effects of periodontal treatment phase I on birth term and birth weight. J Indian Soc Pedod Prev Dent 24: 23-26.
88. Staten M. (2004). Biomarkers and clinical trials: case studies from diabetes. In: Methods for enhancing the efficiency of dental/oral health clinical trials: current status, future possibilities. Barnett ML, Pihlstrom BL, editors. J Dent Res 83: 744-750.
89. Streiner DL (2007). Alternatives to placebo-controlled trials. Can J Neurol Sci 34 (Suppl 1). 37-41.
90. Tarannum F., Faizuddin M. (2007). Effect of periodontal therapy on pregnancy outcome in women affected by periodontitis. J Periodontol 78: 2095-2103.
91. Tonetti MS, DAiuto F., Nibali L., Donald A., Storry C., Parkar M., et al. (2007). Treatment of periodontitis and endothelial function. N Engl J Med 356: 911-920.
92. Tonks A. (1999). Registering clinical trials. BMJ 319: 1565-1568.
93. Turan FN, Senocak M. (2007). Evaluating "superiority", "equivalence" and "non-inferiority" in clinical trials. Ann Saudi Med 27: 284-288.
94. US Department of Health and Human Services Food and Drug Administration (2009). 21CFR Part 872 Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury. Designation of Special Controls for Dental Amalgam, Mercury and Amalgam Alloy; Final Rule August 4, 2009. http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/ DentalProducts/DentalAmalgam/UCM174024.pdf (URL accessed 05/05/2010).
95. US Food and Drug Administration (1996). Good Clinical Practice: Industry Guidance. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ UCM129515.pdf (URL accessed 05/05/2010).
96. Varmus H. (2000). Keynote address: Tools and technologies to enhance clinical research: public-private sector collaborations. In: Biomarkers and surrogate endpoints: clinical research and applications. Proceedings of an NIH-FDA Conference, April 15-16, 1999. Bethesda, MD, USA. Downing GJ, editor. New York: Elsevier Publishers, pp. xi-xiv.
97. Vidal F., Figueredo CM, Cordovil I., Fischer RG (2009). Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 80: 786-791.
98. Wang R., Lagakos SW, Ware JH, Hunter DJ, Drazen JM (2007). Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 357: 2189-2194.
99. Wilhelmsen L. (2002). Role of the Data and Safety Monitoring Committee (DSMC). Stat Med 21: 2823-2929.
100. Wimmer G., Pihlstrom BL (2008). A critical assessment of adverse pregnancy outcome and periodontal disease. J Clin Periodontol 35 (8 Suppl). S380 - S397.
101. World Health Organization (2010). International Clinical Trials Registry Platform (ICTRP). http://www.who.int/ictrp/en/ (URL accessed 05/05/2010).
102. Yeboah J., Folsom AR, Burke GL, Johnson C., Polak JF, Post W., et al. (2009). Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120: 502-509.